Philippe Mazaltarim is a clinician specializing in Transcranial Magnetic Stimulation (rTMS) at Neurotherapy Montreal and played a key role in establishing the Neuromodulation Unit at the McGill University Health Center (MUHC), Royal Victoria Hospital.
His expertise extends across neuromodulation therapies, including Brainport and the PoNS device (Cranial Nerve Non-Invasive Neuromodulation, CN-NINM), reflecting his deep understanding of neuroscience and patient-centered care.
Philippe has a particular focus on treating psychiatric conditions such as depression, anxiety, post-traumatic stress disorder (PTSD), and obsessive-compulsive disorder (OCD). His clinical work also includes managing patients with neurological conditions, including post-stroke recovery and post-concussive symptoms from traumatic brain injuries, as well as neurodegenerative diseases such as multiple sclerosis and Parkinson’s disease.
In addition to his clinical work, he actively contributes to advancing the field as a research assistant in multiple clinical trials, where his commitment to evidence-based practice and innovation in neuromodulation supports the evolution of treatment approaches for neurological and psychiatric disorders.

